Tuesday, June 4, 2013

Logic Sponsors Ablow's E-Cig Study

Electronic cigarette maker Logic Technology recently announced that Keith Ablow, M.D., will be conducting an expanded clinical study of Logic EGO CE4 in his practice to determine their effects on reducing or eliminating tobacco product usage. Previously, Dr. Ablow reported that three individuals had ceased smoking when given e-cigarettes as part of a smoking cessation regimen.

Sponsored by Logic, Dr. Ablow's study will monitor and track patients' experiences using e-cigarettes to determine the product category's effectiveness for transitioning smokers from traditional cigarettes to a tobacco-free, smokeless, battery-operated nicotine delivery device.

The study, to be conducted over a 12-week period, will offer patients who use traditional cigarettes the option to try ego t electronic cigarette. Dr. Ablow will provide participating patients with e-cigarettes and measure their use of this technology and tobacco products over the course of the 12 weeks.

Simulating the feeling and taste of a real cigarette, Logic provides a sensory experience that satisfies a smoker's addictive cravings for the nicotine, tobacco flavor, hand-to-mouth motion and vapor release, while avoiding 4,000 toxins that are in cigarettes, according to the company. Unlike other nicotine delivery devices, an e-cigarette can assuage the desire for a traditional cigarette and deliver a realistic smoking experience, the company added.fsfd3WD3x

"We are thrilled to work with distinguished psychiatrist Dr. Keith Ablow to conduct this study," said Eli Alelov, CEO of Logic Technology, Livingston, N.J. "Minimal statistical data exists about ego-t battery and their effectiveness in supporting a switch from traditional cigarettes, and we think it is imperative to educate the public on the benefits of this product. We think Dr. Ablow's findings will support the rapidly growing industry and prove what we have been saying for years, that Logic is a smarter alternative helping to convert American smokers to better choices."

"I reached out to Logic about this informal, expanded series of clinical case studies because I cannot understand why universities and the government are not aggressively exploring the use of electronic cigarettes to help smokers stop using tobacco," said Ablow. "I am a supporter of rechargeable electronic cigarette in aiding patients to make smarter choices with their smoking habits."

Logic will provide a findings update as the study moves forward.

No comments:

Post a Comment